Canine C-Peptide antibody and antigen (recombinant protein)
Diagnostic anti-Canine C-Peptide antibodies pairs and antigen for animal health (animal Dog/Canine type 1 diabetes mellitus) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-C-Peptide-Ag01 | Recombinant Canine C-Peptide protein | 3090 |
GMP-CAN-C-Peptide-Ab01 | Anti-Canine C-Peptide mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-C-Peptide-Ab02 | Anti-Canine C-Peptide mouse monoclonal antibody (mAb) | 1953 |
GMP-CAN-C-Peptide-Ab03 | Anti-Canine C-Peptide human monoclonal antibody (mAb) | 1953 |
GMP-CAN-C-Peptide-Ab04 | Anti-Canine C-Peptide human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-CAN-C-Peptide-Ag01 |
Product Name | Recombinant Canine C-Peptide protein |
Target/Biomarker | Canine C-peptide (C-Peptide) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine C-peptide antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in C-Peptide level test of animal Dog/Canine with type 1 diabetes mellitus. |
Tag | His |
Products description | Recombinant Canine C-Peptide protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-C-Peptide-Ab01, GMP-CAN-C-Peptide-Ab02 |
Product Name | Anti-Canine C-Peptide mouse monoclonal antibody (mAb) |
Target/Biomarker | Canine C-peptide (C-Peptide) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine C-peptide antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-C-Peptide antibodies in C-Peptide level test of animal Dog/Canine with type 1 diabetes mellitus. |
Tag | mFc |
Products description | Anti-Canine C-Peptide mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-C-Peptide antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-CAN-C-Peptide-Ab03, GMP-CAN-C-Peptide-Ab04 |
Product Name | Anti-Canine C-Peptide human monoclonal antibody (mAb) |
Target/Biomarker | Canine C-peptide (C-Peptide) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Canine C-peptide antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-C-Peptide antibodies in C-Peptide level test of animal Dog/Canine with type 1 diabetes mellitus. |
Tag | hFc |
Products description | Anti-Canine C-Peptide human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-C-Peptide antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Canine C-Peptide, a molecular marvel of 31 amino acids, is intricately woven into the fabric of dogs' metabolic harmony. This peptide is the result of the proteolytic cleavage of proinsulin during its conversion into active insulin. While insulin takes center stage in glucose regulation, C-Peptide quietly plays its role as a companion biomarker, co-secreted alongside insulin by the pancreas. Canine C-Peptide emerges as a sentinel of pancreatic health and insulin production. It mirrors the natural ebb and flow of endogenous insulin secretion, pulsing into circulation in response to rising blood glucose levels. Unlike exogenously administered insulin, which is uniform and continuous, C-Peptide levels follow a distinct pattern that mimics the body's physiological insulin release. This pattern offers a unique window into the functioning of the pancreas, enabling veterinarians to assess the organ's ability to produce insulin. Furthermore, Canine C-Peptide serves as a linchpin in the diagnosis and differentiation of diabetes in dogs. It distinguishes between Type 1 and Type 2 diabetes, two distinct entities in the spectrum of canine diabetes. In Type 1 diabetes, C-Peptide levels are typically low or undetectable, signifying the autoimmune destruction of pancreatic beta cells and the absence of endogenous insulin production. In Type 2 diabetes, C-Peptide levels vary, reflecting the interplay of insulin resistance and impaired insulin secretion. This differentiation is pivotal, as it dictates treatment strategies and guides veterinarians in providing tailored care for dogs.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.